Full Issue

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Jan/Feb 2020 - Volume 24, Number 1

Purchase the entire back issue in electronic PDF or print format.

(Select Format)

Purchase individual articles by selecting the article in the table below...

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Individual Articles - Jan/Feb 2020 - Volume 24, Number 1
PreScription: One Size Does Not Fit All! Allen Loyd V Jr	Jan/Feb 2020 Pg. 4
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets Mulder Kyle	Jan/Feb 2020 Pg. 7-12
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems Vaughn Stacey R, Radwick Allison	Jan/Feb 2020 Pg. 14-19
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk Cabaleiro Joe	Jan/Feb 2020 Pg. 21-27
New and Improved! Brunner Scott	Jan/Feb 2020 Pg. 28-29
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Allen Loyd V Jr	Jan/Feb 2020 Pg. 38-43
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Allen Loyd V Jr	Jan/Feb 2020 Pg. 44-50
Calculations Stockton Shelly J	Jan/Feb 2020 Pg. 52
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jan/Feb 2020 Pg. 54
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 55
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 56
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 57
Isoniazid 10 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2020 Pg. 58
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 59
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2020 Pg. 60
Potassium Chloride 1 mmol/mL in Ora-Sweet SF Allen Loyd V Jr	Jan/Feb 2020 Pg. 61
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Allen Loyd V Jr	Jan/Feb 2020 Pg. 62
Venlafaxine 15 mg/mL in Syrup Allen Loyd V Jr	Jan/Feb 2020 Pg. 63
Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M	Jan/Feb 2020 Pg. 64-68
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha	Jan/Feb 2020 Pg. 69-76
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James	Jan/Feb 2020 Pg. 77-82
Compatibility of Melphalan in Iodinated Contrast Media Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin	Jan/Feb 2020 Pg. 83-85
Errata - How to Qualify Container Closure Systems for Intended Use, Part 1 - IJPC 23(6) 454-461	Jan/Feb 2020 Pg. 86-87 View Sample
Return to Top

	PDF — $95
	Print Copy — $95